高风险神经母细胞瘤治疗的向疗法:需要整合监管和科学工具

Adriana Ceci1, Rosa Conte1, Antonella Didio1

  • 1Research Department, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy.

Frontiers in medicine
|July 31, 2023
PubMed
概括

开发新的神经母细胞瘤治疗方法面临监管障碍. 对活性物质的审查发现了许多早期试验,但很少获得监管批准,凸显了改善儿科药物开发模型的需要.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K